Categories: HealthcareNews

ProAssurance Announces Dates for Release of Third Quarter 2023 Results Release and Investor Teleconference

BIRMINGHAM, Ala.–(BUSINESS WIRE)–ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended September 30, 2023 after the close of normal New York Stock Exchange trading on Wednesday, November 8, 2023.


ProAssurance will conduct a conference call at 10:00 AM ET on Thursday, November 9, 2023 to discuss the results and other items of interest to investors participating in the call. We invite US-based investors to participate by dialing either (833) 470-1428 (toll free) or (404) 975-4839. International investors are invited to participate using country-specific dial-in numbers that may be found using this link: https://www.netroadshow.com/events/global-numbers?confId=53156. The access code for all attendees is 198658.

Callers may also pre-register at to receive unique call access details and avoid operator wait times; pre-register here if desired: https://www.netroadshow.com/events/login?show=477bea77&confId=56230.

The conference call will also be webcast at https://events.q4inc.com/attendee/957118896.

A telephone replay of the call will be available for at least 7 days after the call date. US-based investors my access the replay by dialing (866) 813-9403 (toll free) or (929) 458-6194, and international investors may dial +44 (204) 525-0658. The access code for all attendees is 484795. A replay will be available for at least one year after the call date at ProAssurance.com.

About ProAssurance

ProAssurance Corporation is an industry-leading specialty insurer with extensive expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers’ compensation insurance. ProAssurance Group is rated “A” (Excellent) by AM Best. ProAssurance and its operating subsidiaries carry a Financial Strength Rating of “A-” (Strong) from Fitch Ratings.

For the latest on ProAssurance and its industry-leading suite of products and services, cutting-edge risk management and practice enhancement programs, follow @ProAssurance on Twitter or LinkedIn. ProAssurance’s YouTube channel regularly presents thought provoking, insightful videos that communicate effective practice management, patient safety and risk management strategies.

Contacts

Dana Hendricks, EVP, Chief Financial Officer

800-282-6242 • 205-877-4462 • DanaHendricks@ProAssurance.com

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

6 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

9 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

9 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

9 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

9 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

9 hours ago